LEADER 01977nam  2200433z- 450 
001 9910261138603321
005 20231214133149.0
035   $a(CKB)4100000002484706
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54430
035   $a(EXLCZ)994100000002484706
100   $a20202102d2017      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNephrotic Syndrome in Pediatric Patients
210   $cFrontiers Media SA$d2017
215   $a1 electronic resource (85 p.)
225 1 $aFrontiers Research Topics
311   $a2-88945-298-0 
330   $aNephrotic syndrome (NS) - characterized by heavy glomerular protein loss (proteinuria), edema, hypoalbuminemia, and hyperlipidemia - has diverse causes and frequently leads to chronic kidney disease. This E-book encompasses articles on a variety of topics in NS, including a historical perspective on understanding and treatment of NS, followed by state-of-the-art reviews of the molecular pathomechanisms, clinical outcomes, as well as current and emerging treatment strategies for NS. We hope that this comprehensive review will help to reduce the gaps between the research and the day-to-day care of patients with NS and inspire new research efforts towards updating and expanding the treatment armamentarium for the future.
610   $aedema
610   $apodocytes
610   $aproteinuria
610   $aFSGS
610   $aslit diaphragm
610   $aminimal change disease
610   $aAPOL1
610   $aprednisone
610   $anephrotic syndrome
610   $acalcineurin inhibitors
700   $aFrederick Jeffrey Kaskel$4auth$01329296
702   $aAgnieszka Swiatecka-Urban$4auth
702   $aRobert P. Woroniecki$4auth
906   $aBOOK
912   $a9910261138603321
996   $aNephrotic Syndrome in Pediatric Patients$93039396
997   $aUNINA